We are live on ! Find out more
ENZ

Enzo Biochem, Inc.
ENZ

Delisted

ENZ was delisted on the 17th of April, 2025.

Back to rankings

109 hedge funds and large institutions have $237M invested in Enzo Biochem, Inc. in 2017 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 37 increasing their positions, 35 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

56% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 9

26% more capital invested

Capital invested by funds: $188M → $237M (+$48.7M)

6% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 35

0% more funds holding

Funds holding: 109 → 109 (0)

Holders
109
Holders Change
–
Holders Change %
0%
% of All Funds
2.71%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
14
Increased
37
Reduced
35
Closed
9
Calls
$357K
Puts
–
Net Calls
+$357K
Net Calls Change
-$10K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$22.4M
2
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$2.7M
3
CA
Corrado Advisors
New Jersey
+$2.12M
4
PI
Putnam Investments
Massachusetts
+$1.82M
5
MAG
Millrace Asset Group
Pennsylvania
+$1.06M

Top Sellers

Rank Fund Capital Flow
1
GC
Globeflex Capital
California
-$1.42M
2
EI
EAM Investors
California
-$661K
3
BCM
Bridgeway Capital Management
Texas
-$634K
4
Morgan Stanley
Morgan Stanley
New York
-$610K
5
PA
Perceptive Advisors
New York
-$582K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS AM
101
UBS AM
Illinois
$2.98K – – –
CCMW
102
Cypress Capital Management (Wyoming)
Wyoming
$2.3K +$1.94K +275 New
HI
103
Hudock Inc
Pennsylvania
$2K – – –
YWP
104
YorkBridge Wealth Partners
New York
$2K – – –
CHC
105
City Holding Co
West Virginia
$1K – – –
FWM
106
Focused Wealth Management
New York
$1K – – –
BNP Paribas Financial Markets
107
BNP Paribas Financial Markets
France
$670 -$3.34K -474 -86%
Walleye Trading
108
Walleye Trading
New York
$271 -$40.2K -5,700 -15%
PA
109
Perceptive Advisors
New York
– -$582K -83,893 Closed
Susquehanna International Group
110
Susquehanna International Group
Pennsylvania
– -$422K -59,969 Closed
CS
111
Credit Suisse
Switzerland
– -$196K -28,192 Closed
TCM
112
Teza Capital Management
Illinois
– -$102K -14,636 Closed
Squarepoint
113
Squarepoint
New York
– -$78K -11,238 Closed
Fuller & Thaler Asset Management
114
Fuller & Thaler Asset Management
California
– -$65K -9,300 Closed
CCMH
115
Cornerstone Capital Management Holdings
New York
– -$48K -7,000 Closed
TRCT
116
Tower Research Capital (TRC)
New York
– -$5K -718 Closed
ClearBridge Investments
117
ClearBridge Investments
New York
– -$2K -329 Closed
1 2 3 4
5

ENZ Hedge Fund Activity: Q1 2017 in Review

109 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q1 2017, worth a combined $237M — up 26% from $188M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ENZ positions and 9 closed out — a net gain of 5 holders — while 37 added to existing stakes and 35 trimmed.

The largest buyer was BlackRock, adding an estimated $22.4M. The largest seller was Globeflex Capital, cutting an estimated $1.42M.

  • 109 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q1 2017, unchanged from Q4 2016.
  • Funds reported $237M of Enzo Biochem, Inc. stock for Q1 2017, up 26% quarter-over-quarter.
  • 14 funds opened new Enzo Biochem, Inc. positions in Q1 2017 and 9 closed out, a net change of +5 holders.
  • The largest Enzo Biochem, Inc. buyer in Q1 2017 was BlackRock, an estimated $22.4M added.
  • The largest Enzo Biochem, Inc. seller in Q1 2017 was Globeflex Capital, an estimated $1.42M sold.

Based on aggregated 13F filings for Q1 2017.